Sarcina A, Bellosta R, Luzzani L, Agrifoglio G
Institute of Vascular Surgery, University of Milan, Italy.
J Cardiovasc Surg (Torino). 1997 Aug;38(4):347-54.
A retrospective study to evaluate the treatment, long term follow-up and factors affecting revascularization results particularly in regard to clinical presentation and prosthetic materials used after 20 years of experience.
Between 1974 and September 1995 there were 67 popliteal aneurysms in 58 patients. Three patients underwent a primary amputation because of irreversible ischaemia and 3 patients a surgical sympathectomy. Operative repair was performed in 61 cases: as an emergency in 9 (14.7%) limbs and as an elective procedure in 52 (85.3%) limbs. Graft replacement was performed employing polytetrafluoroethylene (PTFE) grafts in 34 (55.7%) cases 13 of which with Ringed PTFE, autogenous saphenous vein in 10 (16.4%) cases and Dacron in 17 (27.9%).
The cumulative primary patency (CP) and limb salvage rate (LS) at 10 years were 75.1% and 83.3% respectively. We divided the patients into two groups: asymptomatic (Group I) and symptomatic with limb threatening ischemia (Group II). At 10 years the CP in Group I and II were 78.2% vs 67.2% respectively (p < 0.05 at 18 months) and the LS 87.4% vs 74.6% (p < 0.05). There was no statistical difference in terms of CP and LS rate between saphenous vein and PTFE. The use of PTFE grafts avoided harvesting of the long saphenous vein; this resulted in a significantly reduced operation time (135 +/- 18.6 vs 195 +/- 22.4 minutes, p < 0.001) and length of stay (7.4 vs 8.8 days, p < 0.02).
We conclude that elective repair is indicated in all patients with popliteal aneurysm > or = 2 cm to avoid a critical ischemia with poorer results in terms of CP and LS. In the last 3 years our technique of choice is the exclusion of the aneurysm with a short PTFE bypass with good long-term of CP and LS rates.
进行一项回顾性研究,以评估腘动脉瘤的治疗、长期随访以及影响血管重建结果的因素,特别是在20年的经验积累后,关于临床表现和所使用的假体材料方面。
1974年至1995年9月期间,58例患者中有67个腘动脉瘤。3例患者因不可逆性缺血接受了一期截肢,3例患者接受了手术交感神经切除术。61例患者进行了手术修复:9例(14.7%)肢体为急诊手术,52例(85.3%)肢体为择期手术。34例(55.7%)患者采用聚四氟乙烯(PTFE)移植物进行移植置换,其中13例使用带环PTFE;10例(16.4%)患者使用自体大隐静脉;17例(27.9%)患者使用涤纶移植物。
10年时的累积原发性通畅率(CP)和肢体挽救率(LS)分别为75.1%和83.3%。我们将患者分为两组:无症状组(I组)和有肢体威胁性缺血的症状组(II组)。10年时,I组和II组的CP分别为78.2%和67.2%(18个月时p<0.05),LS分别为87.4%和74.6%(p<0.05)。大隐静脉和PTFE在CP和LS率方面无统计学差异。使用PTFE移植物避免了大隐静脉的采集;这导致手术时间显著缩短(135±18.6分钟对195±22.4分钟,p<0.001)和住院时间缩短(7.4天对8.8天,p<0.02)。
我们得出结论,所有腘动脉瘤直径≥2 cm的患者均应进行择期修复,以避免严重缺血,因为在CP和LS方面结果较差。在过去3年中,我们选择的技术是用短PTFE旁路排除动脉瘤,CP和LS率长期良好。